Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zachary Leitze

Orthopaedic Surgery St George, UT Medical Doctor

NPI 1053341115 CMS profile 138757

652 S Medical Center Dr, Suite 120, St George, UT 84790

Open in the dashboard

General payments

$809,449

154 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$247,650

6 holdings reported · through program year 2025

Through program year 2025, Zachary Leitze of St George, UT is reported in the CMS Open Payments database as having received $809,449 across 154 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $247,650 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $291,394 11
2024 General $222,145 32
2023 General $176,394 36
2022 General $83,319 30
2021 General $24,157 13
2020 General $4,128 6
2019 General $7,911 26
2025 Ownership $13,992 1
2024 Ownership $13,992 1
2023 Ownership $13,992 1
2022 Ownership $76,212 1
2021 Ownership $67,848 1
2020 Ownership $61,614 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Leitze
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Zachary Leitze were reported at $291,394. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Zachary Leitze Orthopaedic Surgery median Middle half National median
2019 $7,911 $644 $140–$2,844 $163
2020 $4,128 $312 $75–$1,860 $114
2021 $24,157 $520 $117–$2,495 $132
2022 $83,319 $598 $128–$2,731 $149
2023 $176,394 $461 $128–$2,264 $160
2024 $222,145 $497 $134–$2,475 $164
2025 $291,394 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Catalyst OrthoScience $762,246 48 payments
  2. Encore Medical, LP $32,676 44 payments
  3. Medacta USA, Inc. $7,255 21 payments
  4. Goode Surgical Inc $4,021 11 payments
  5. Arthrex, Inc. $2,301 19 payments
  6. Stryker Corporation $354 4 payments
  7. Orthalign Inc $346 2 payments
  8. Exactech, Inc. $184 1 payment
  9. Shoulder Innovations, Inc. $29 1 payment
  10. DePuy Synthes Sales Inc. $24 2 payments
  11. Other $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $568,276 16 payments
  2. Consulting Fee $217,360 26 payments
  3. Travel and Lodging $15,369 30 payments
  4. Education $4,361 5 payments
  5. Food and Beverage $4,084 77 payments
Products named General payments · program years 2019–2025
  1. R1 Reverse Shoulder System $289,560 7 payments
  2. Catalyst Total CSR $233,643 14 payments
  3. Catalyst CSR Shoulder System $213,100 6 payments
  4. Archer CSR Total Shoulder System $22,428 4 payments
  5. Archer R1 Reverse Shoulder System $22,428 4 payments
  6. DJO SURGICAL Joint Implants $22,091 14 payments
  7. DJO SURGICAL Joint Implants $12,524 3 payments
  8. DJO Surgical AltiVate Reverse $8,160 15 payments
  9. Shoulder System $7,156 20 payments
  10. DJO Surgical AltiVate Anatomic System $5,556 19 payments
  11. Other $23,022 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$267,026

Of which drugs: $890

Medicare patients

387

Average age 75

Services billed

1,181

209 women, 178 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Depression 28%
Diabetes 24%
Ischemic heart disease 22%
Chronic kidney disease 20%
Osteoporosis 18%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 48 246 $174

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record